Medicina de Família
Estudo da WHO estima que longas horas de trabalho causam 745 mil mortes ao ano por doença cardíaca e AVC.
18 Mai, 2021 | 10:45hComunicado de imprensa: Long working hours increasing deaths from heart disease and stroke: WHO, ILO – World Health Organization
Comentário: Long working hours killing 745,000 people a year, study finds – BBC
Comentário no Twitter (fio – clique para saber mais)
🆕 WHO & @ilo analysis shows that working 55 hours or more per week impacts #WorkersHealth & increases risk of cardiovascular diseases.
Long working hours led to 745 000 deaths from #stroke & ischemic heart disease in 2016, a 2⃣9⃣% rise ↗️ since 2000.
👉 https://t.co/T3nuPX3nH7 pic.twitter.com/UW5XxbjWqo
— World Health Organization (WHO) (@WHO) May 17, 2021
Opinião | Cigarros eletrônicos e o banimento de cigarros mentolados nos Estados Unidos: uma oportunidade perdida de proteger os jovens.
18 Mai, 2021 | 10:43hE-Cigarettes and the U.S. Menthol Ban: A Missed Opportunity to Protect Youth – Think Global Health
Comentário no Twitter (fio – clique para saber mais)
📢📢📢 @US_FDA should ban flavors in all nicotine-containing products, not just menthol cigarettes. More than 8 out of 10 current youth e-cigarette users in the U.S. vape non-tobacco flavors.
IHME researchers for @ThinkGlobalHlth 🧵⤵️ https://t.co/d56mDCvTY3
— Institute for Health Metrics and Evaluation (IHME) (@IHME_UW) May 17, 2021
Revisão sistemática: Tratamento da doença do refluxo gastresofágico no auxílio ao manejo da asma em adultos e crianças pode reduzir o uso de medicamentos de resgate, mas os benefícios sobre o número de exacerbações e internações permanecem incertos.
18 Mai, 2021 | 10:42hAtualização da Diretriz NICE | Cefaleias em maiores de 12 anos: diagnóstico e tratamento.
18 Mai, 2021 | 10:35hHeadaches in over 12s: diagnosis and management – National Institute for Health and Care Excellence
Perspectiva: Não existe “coração de Covid”.
17 Mai, 2021 | 09:41hSetting the record straight: There is no ‘Covid heart’ – STAT
Comentário no Twitter
Why the issue of Covid-19 induced cardiac problems was massively overblown and why screening low-risk patients with MRI and other fancy tests is neither necessary nor wise. https://t.co/HkJFOJ6oeM
— Raffaele Rasoini (@RasoiniR) May 14, 2021
#ACC21 – Estudo randomizado: Não há diferenças significativas em eventos cardiovasculares ou sangramento maior entre pacientes que recebem diariamente 81 mg vs. 325 mg de aspirina.
17 Mai, 2021 | 09:29hComparative Effectiveness of Aspirin Dosing in Cardiovascular Disease – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comentários: High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE – TCTMD E Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-Term Effectiveness – ADAPTABLE – American College of Cardiology
Vídeo: Aspirin Dosing: A Patient-centric Trial Assessing Benefits And Long-term Effectiveness Trial
#ACC21 – Estudo randomizado: Programa de reabilitação precoce e personalizado para insuficiência cardíaca traz benefícios físicos e emocionais para pacientes idosos.
17 Mai, 2021 | 09:26hComentários: Tailored, earlier heart failure rehab has physical, emotional benefits for patients – National institutes of Health E REHAB-HF: Tailored Cardiac Rehab Program Improved Function and Quality of Life in Older HF Patients – American College of Cardiology E Rehabilitation Therapy in Older Acute Heart Failure Patients – REHAB-HF – American College of Cardiology
Comentários no Twitter
#REHAB-HF #ACC21 innovative intensive rehab improved physical function
-attention to SDOH environment assessment & involvement of family/care givers
-q2 wk trouble shooting discussion
-corrected balance/mobility first to get pts on treadmill w confidence https://t.co/rOmsc6qdq3 pic.twitter.com/V8TugBipUT— Ritu Thamman MD (@iamritu) May 16, 2021
REHAB-HF trial results found novel #CVRehab program tailored to address specific physical impairments in frail/older patients w/ acute #HeartFailure improved physical function & quality of life; did not significantly reduce hospitalizations. https://t.co/f98IdMvqj4 #ACC21 #cvGeri pic.twitter.com/zY8E1WBNmf
— American College of Cardiology (@ACCinTouch) May 16, 2021
2 metanálises recentes destacam os benefícios de dupla antiagragação plaquetária com clopidogrel + aspirina por até 30 dias para pacientes com ataque isquêmico transitório de alto risco ou AVC isquêmico leve-moderado.
17 Mai, 2021 | 09:21hMetanálise 2: Efficacy and Safety of Using Dual Versus Monotherapy Antiplatelet Agents in Secondary Stroke Prevention: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials – Circulation (link para o resumo – $ para o texto completo)
Comentário: Dual vs. Monotherapy Antiplatelet Agents in Secondary Stroke Prevention – American College of Cardiology
Diretriz relacionada: Dual antiplatelet therapy with aspirin and clopidogrel for acute high risk transient ischaemic attack and minor ischaemic stroke – The BMJ
Cuidado desnecessário? 1 em 3 pacientes com demência avançada e fibrilação atrial ainda recebem anticoagulantes.
17 Mai, 2021 | 09:19hEstudo original: Anticoagulant Use for Atrial Fibrillation Among Persons With Advanced Dementia at the End of Life – JAMA Internal Medicine (gratuito por período limitado)
Editorial: Anticoagulation at the End of Life: Time for a Rational Framework (gratuito por período limitado)
Relatório: Implementação de cuidado primário de alta qualidade – “pague para equipes de cuidado primário cuidarem das pessoas, e não para médicos prestarem serviços.”
17 Mai, 2021 | 09:18hRelatório original: Implementing High-Quality Primary Care: Rebuilding the Foundation of Health Care – National Academies of Sciences, Engineering, and Medicine